[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Vincent COTTIN\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":38},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":14,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":4,"briefSummary":22,"conditions":23,"keywords":25,"overallStatus":26,"whyStopped":4,"lastUpdateSubmitDate":27,"lastUpdatePostDateStruct":28,"startDateStruct":31,"completionDateStruct":33,"leadSponsor":35,"locationsCount":5},"100169823","national-lymphangioleiomyomatosis-registry-france-100169823",false,"NCT01484236","National Lymphangioleiomyomatosis Registry, France","RE-LAM-CE","Inclusion Criteria:\n\n* Patients with sporadic lymphangioleiomyomatosis or associated with Tuberous sclerosis.\n* patients diagnosed or hospitalized or seen in consultation since 01\u002F01\u002F2008\n\nExclusion Criteria:\n\n* None","ALL","18 Years",{"count":19,"type":20},200,"ESTIMATED","OBSERVATIONAL","RE-LAM-CE is a registry of lymphangioleiomyomatosis cases in France. its aim is to determine the incidence and prevalence of lymphangioleiomyomatosis in France, including demographic information and information concerning the timing and modalities of diagnosis.\n\nBased on the registry, we will set up a prospective cohort of patients. The database will include detailed medical information, particularly regarding progression of the respiratory function.",[24],"Lymphangioleiomyomatosis",[24],"RECRUITING","2025-03-11",{"date":29,"type":30},"2025-03-13","ACTUAL",{"date":32,"type":4},"2012-01",{"date":34,"type":20},"2026-12",{"name":36,"class":37},"Vincent COTTIN","OTHER",""]